CLINICAL OUTCOMES OF A NEW ENHANCED DEPTH OF FOCUS INTRAOCULAR LENS

Published 2022 - 26th ESCRS Winter Meeting

Reference: FP40 | Type: Abstracts | DOI: 10.82333/hz3e-6840

Authors: Pedro Carreira* ¹ , Tomás Loureiro ¹ , Sandra Rodrigues-Barros ¹ , Ana Rita Carreira ¹ , Filipe Moraes ¹ , Diogo Lopes ¹ , Audrey Sampaio ¹ , Inês Machado ¹ , Nuno Campos ¹

¹Ophthalmology,Hospital Garcia de Orta,Lisboa,Portugal

Purpose

To assess the clinical outcomes and patient satisfaction of the new enhanced depth of focus (EDOF) LuxSmart^TM IOL and to compare with a conventional monofocal IOL (Akreos^TM) in patients who had undergone bilateral cataract surgery.

Setting

Hospital Garcia de Orta

Methods

Twelve patients underwent bilateral LuxSmart^TM IOL implantation and twelve underwent bilateral Akreos^TM IOL implantation. Best-corrected distance (CDVA) and uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA) at 66cm, uncorrected near visual acuity (UNVA) at 40cm and defocus curve were assessed. Patients-reported visual function was inquired by Catquest-9SF. The presence of photic phenomena was evaluated. A p-value lower than 0.05 was considered for statistical significance.

Results

The mean IOL power was +21.90D in LuxSmart^TM group and +22.30D in Akreos^TM. Monocular UDVA (p=0.32) and CDVA (p=0.52) did not differ between groups. The average binocular UIVA (0.18 ± 0.12 logMAR vs. 0.30 ± 0.13 logMAR, p<0.001) and UNVA (0.38 ± 0.14 logMAR vs. 0.44 ± 0.17 logMAR, p=0.02) were higher in LuxSmart^TM IOL group. No patients reported disabling photic phenomena in either group.

Conclusion

This study shows that new LuxSmart^TM EDOF IOL achieved higher performance for intermediate and near vision compared with a conventional monofocal IOL, without increasing the risk of dysphtopsias. LuxSmart^TM may be an attractive and safe option for patients who desire spectacle independence for distance and intermediate vision after cataract surgery.